Broadening OPTIONs for LAA closure: innovations and outcomes
Sponsored by Boston Scientific
LAA Closure
Symposium with Recorded case
Boston Scientific
Room 251
Anchorperson: Jens Erik Nielsen-Kudsk
Spokesperson: Carsten Skurk
Discussants: Adel Aminian, Livia Luciana Gheorghe, Lorenz Räber, Apostolos Tzikas
Watch this session if you want
- To discuss the clinical data from the OPTION trial and its implications for practice
- To understand how OPTION trial findings could influence clinical decision-making
- To discover upcoming innovations in the WATCHMAN FLX product pipeline
Welcome and session objectives
Jens Erik Nielsen-Kudsk
Recorded case part 1: a patient case
Lorenz Räber
OPTION study and the role of the interventional cardiologist
Livia Luciana Gheorghe
Medication adherence: the elephant in the room
Apostolos Tzikas
Discussion and audience interaction
Recorded case part 2: the procedure
Lorenz Räber
Discussion and audience interaction
Anatomical considerations for LAA closure
Adel Aminian
My patient has a very large LAA
Jens Erik Nielsen-Kudsk
Discussion and audience interaction
Session evaluation and key learnings
Carsten Skurk
